reported that TP53 mutations enhance oncogenic potential and confer stem‐like characteristics in CRC cells [45], a phenomenon also observed in breast cancer [46] and osteosarcoma [47], underscoring the regulatory role of TP53 in CSC biology. The gene discussed is TP53; the disease is colorectal carcinoma.